J&J announces collaboration with U-M startup HistoSonics for non-invasive solid tumor treatment

1/11/2016

Although surgical resection remains the gold standard treatment for solid tumors, approximately 85 percent of patients are not candidates for surgical resection, particularly those with cancers of the liver and pancreas. Ethicon Endo-Surgery, Inc. has entered into a collaboration with HistoSonics, a company developing histotripsy, a non-invasive soft tissue ablation modality that mechanically homogenizes target tissue, resulting in complete cellular destruction…